Ohb Neonatology Limited
- Address
- 1 Ashley Road
Sponsor Overview
Specializations
Neonatal Respiratory Medicine
Ohb Neonatology Limited focuses on chronic lung disease in extremely premature infants, with particular attention to bronchopulmonary dysplasia and related respiratory complications in the neonatal period.
- Chronic lung disease
- Bronchopulmonary dysplasia
- Extremely premature babies
The sponsor’s research activity is centered on outcomes linked to severe respiratory morbidity and early-life survival in vulnerable newborn populations.
Perinatal and Neonatal Care
The clinical focus extends to the management of perinatal and neonatal complications associated with extreme prematurity, including conditions that affect lung development and respiratory stability after birth.
- Perinatal care
- Neonatal care
- Respiratory stability
Research interest is directed toward care settings where early respiratory support and long-term pulmonary health are central concerns.
Paediatric Pulmonary Outcomes
Its trial activity is aligned with paediatric pulmonary outcomes, especially measures that reflect the burden of persistent lung disease and the risk of severe respiratory impairment in infancy.
- Paediatric pulmonary outcomes
- Severe respiratory impairment
- Infant lung health
Attention is placed on clinical endpoints relevant to lung function, disease severity, and survival in the first weeks of life.
Therapeutic Development for Rare Infant Conditions
As a pharmaceutical company, the sponsor is involved in therapeutic development for a specialised rare disease setting, with work directed toward treatment options for neonatal respiratory disease in a highly vulnerable population.
- Rare disease therapeutics
- Neonatal treatment development
- Respiratory disease intervention
The research landscape reflects interest in interventions intended for infants at highest risk of chronic pulmonary complications.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Mecasermin Rinfabate for the Prevention of Bronchopulmonary Dysplasia in Extremely Premature Neonates: A Randomized, Open-label, Phase 2b Study |  Finland Germany Ireland Italy Portugal Spain The Netherlands | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 15 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
15 centres- Address
- De Boelelaan 1117, 1081 HV Amsterdam
- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Largo Giovanni Alessandro Brambilla 3, 50134 Florence
- Address
- Piazzale Ospedale 1, 31100 Treviso
- Address
- Largo Professor Abel Salazar, 4050-011 Porto
- Address
- Wilton Road, T12 YE02 Cork
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Ohb Neonatology Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.